Story thread · 2 reports / 2 sources
Drugmakers, retailers must face ‘maximum strength’ claim in decongestant false ad litigation in US
thedailyrecord.com · 11d
How the coverage leans
Across 2 sources · syndicated copies counted once
The 2nd U.S. Circuit Court of Appeals revived claims against drugmakers and retailers over false 'maximum strength' decongestant labeling despite FDA preemption. The post Drugmakers, retailers must face ‘maximum strength’ claim in decongestant false ad litigation in US appeared first on Maryland Daily Record .
First report: Drugmakers, retailers must face ’maximum strength’ claim in decongestant false ad litigation in US — investing.com, 11d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.